Effect of rapeseed peptide on DNA damage and apoptosis in Hela cells

Zhaohui Xue1, Zhiwei Liu, Moucheng Wu

  • 1School of Agriculture and Bioengineering, Tianjin University, Tianjin 300072, PR China.

Insights

Rapeseed peptide (RSP) shows anticancer potential by inhibiting human cervical carcinoma (Hela) cell proliferation and inducing apoptosis. This study highlights RSP as a promising antitumor compound.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Rapeseed peptide (RSP), derived from rapeseed protein, exhibits anticancer properties.
  • Cervical carcinoma, specifically Hela cells, remains a significant health concern requiring novel therapeutic strategies.

Purpose of the Study:

  • To investigate the anticancer effects of RSP on Hela cells.
  • To elucidate the mechanisms underlying RSP's antitumor activity, including effects on proliferation, DNA damage, cell cycle, and apoptosis.

Main Methods:

  • MTT assay for cell proliferation assessment.
  • Transmission electron microscopy (TEM) for morphological changes.
  • Comet assay for DNA damage evaluation.
  • Cell cycle analysis.

Main Results:

  • RSP significantly inhibited Hela cell proliferation in a dose-dependent manner.
  • RSP induced significant DNA damage and characteristic apoptotic morphological changes in Hela cells.
  • RSP treatment led to S-phase cell cycle arrest and apoptosis induction.

Conclusions:

  • Rapeseed peptide demonstrates potent antitumor activity against Hela cells.
  • The mechanism of action involves inducing DNA damage, cell cycle arrest, and apoptosis.
  • RSP is a potential candidate for developing novel anticancer therapies.

Related Concept Videos